Evidence map›Paper›PMID 38323317›Full record

ArticleTheranostics2024

A novel approach to guide GD2-targeted therapy in pediatric tumors by PET and [

Nils Florian Trautwein, Johannes Schwenck, Christian Seitz, Ferdinand Seith, Eduardo Calderón, Sebastian von Beschwitz, Stephan Singer, Gerald Reischl, Rupert Handgretinger, Jürgen Schäfer and 5 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Theranostics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Theranostics for Neuroblastoma: Making Molecular Radiotherapy Work Better.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2025
    Article
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 2 countries.

Nils Florian TrautweinDepartment of Nuclear Medicine and Clinical Molecular Imaging, University of Tübingen.
Johannes SchwenckDepartment of Nuclear Medicine and Clinical Molecular Imaging, University of Tübingen.
Christian SeitzCluster of Excellence iFIT (EXC 2180) "Image-Guided and Functionally Instructed Tumor Therapies", University of Tübingen.
Ferdinand SeithDepartment of Diagnostic and Interventional Radiology, University of Tübingen.
Eduardo CalderónDepartment of Nuclear Medicine and Clinical Molecular Imaging, University of Tübingen.
Sebastian von BeschwitzDepartment of Nuclear Medicine and Clinical Molecular Imaging, University of Tübingen.
Stephan SingerDepartment of Pathology, Eberhard Karls University Tübingen, 72076 Tübingen, Germany.
Gerald ReischlWerner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, University of Tübingen.
Rupert HandgretingerDepartment of Pediatric Hematology and Oncology, University of Tübingen.
Jürgen SchäferDepartment of Diagnostic and Interventional Radiology, University of Tübingen.
Peter LangDepartment of Pediatric Hematology and Oncology, University of Tübingen.
Bernd J PichlerWerner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, University of Tübingen.
Johannes H SchulteDepartment of Pediatric Hematology and Oncology, University of Tübingen.
Christian la FougèreDepartment of Nuclear Medicine and Clinical Molecular Imaging, University of Tübingen.
Helmut DittmannDepartment of Nuclear Medicine and Clinical Molecular Imaging, University of Tübingen.
University of Tübingen · DEDeutschen Konsortium für Translationale Krebsforschung · DEImaging Center · USSiemens (Germany) · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antibodies, MonoclonalNeuroblastomaChildHumansPositron-Emission TomographyAntibodies, Monoclonaldinutuximab

Identifiers

PMID38323317
PMCPMC10845206
OpenAlexW4391581800

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.